We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ivax Diagnostics, Inc. | AMEX:IVD | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
*
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ERBA Diagnostics Mannheim GmbH
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
þ
(b)
o
|
||||
3
|
SEC USE ONLY
|
||||
4
|
SOURCE OF FUNDS (See Instructions)
WC, OO
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
o
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Germany
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
60,034,713
|
||
8
|
SHARED VOTING POWER
0
|
|||
9
|
SOLE DISPOSITIVE POWER
60,034,713
|
|||
10
|
SHARED DISPOSITIVE POWER
0
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
60,034,713
|
||||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions)
o
|
||||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
88.7%
|
||||||
14
|
TYPE OF REPORTING PERSON (See Instructions)
CO
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Transasia Bio-medicals Ltd.
|
|||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
þ
(b)
o
|
|||||
3
|
SEC USE ONLY
|
|||||
4
|
SOURCE OF FUNDS (See Instructions)
AF, OO
|
|||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
o
|
|||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
India
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
60,034,713
|
|
8
|
SHARED VOTING POWER
0
|
||
9
|
SOLE DISPOSITIVE POWER
60,034,713
|
||
10
|
SHARED DISPOSITIVE POWER
0
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
60,034,713
|
||||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions)
o
|
||||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
88.7%
|
||||||
14
|
TYPE OF REPORTING PERSON (See Instructions)
CO
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Erba Lachema s.r.o.
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
þ
(b)
o
|
||||
3
|
SEC USE ONLY
|
||||
4
|
SOURCE OF FUNDS (See Instructions)
WC, OO
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
o
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Czech Republic
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
8,400
|
||
8
|
SHARED VOTING POWER
0
|
|||
9
|
SOLE DISPOSITIVE POWER
8,400
|
|||
10
|
SHARED DISPOSITIVE POWER
0
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,400
|
||||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions)
o
|
||||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.01%
|
||||||
14
|
TYPE OF REPORTING PERSON (See Instructions)
CO
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Suresh H. Vazirani
|
||||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
þ
(b)
o
|
||||||
3
|
SEC USE ONLY
|
||||||
4
|
SOURCE OF FUNDS (See Instructions)
AF, OO
|
||||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
o
|
||||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
India
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
60,034,713*
|
|||||
8
|
SHARED VOTING POWER
0
|
||||||
9
|
SOLE DISPOSITIVE POWER
60,034,713*
|
||||||
10
|
SHARED DISPOSITIVE POWER
0
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
60,034,713*
|
||||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions)
o
|
||||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
88.7%
*
|
||||||
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Kishore Dudani
|
||||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
þ
(b)
o
|
||||||
3
|
SEC USE ONLY
|
||||||
4
|
SOURCE OF FUNDS (See Instructions)
OO
|
||||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
o
|
||||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
India
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
0
|
|||||
8
|
SHARED VOTING POWER
0
|
||||||
9
|
SOLE DISPOSITIVE POWER
0
|
||||||
10
|
SHARED DISPOSITIVE POWER
0
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
60,034,713*
|
||||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions)
o
|
||||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
88.7%*
|
||||||
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
(a)
|
See Item 11 and Item 13 of each cover page (1)
|
(b)
|
See Items 7 through 10 of each cover page (1)
|
(d)
|
Not applicable
|
(e)
|
Not applicable
|
|
Exhibit 10.1
|
Stock Purchase Agreement, dated April 8, 2011, by and between IVAX Diagnostics, Inc. and ERBA Diagnostics Mannheim GmbH (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K, filed with the Securities and Exchange Commission on April 8, 2011)
|
|
Exhibit 10.2
|
Form of Warrant to Purchase Shares of Common Stock of IVAX Diagnostics, Inc. (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K, filed with the Securities and Exchange Commission on April 8, 2011)
|
|
Exhibit 99.1
|
Joint Filing Agreement, dated September 2, 2010, by and among ERBA Diagnostics Mannheim GmbH, Transasia Bio-medicals Ltd., Erba Lachema s.r.o., Suresh H. Vazirani and Kishore Dudani (incorporated by reference to Exhibit 99.1 to Schedule 13D, filed with the Securities and Exchange Commission on September 2, 2010)
|
ERBA DIAGNOSTICS MANNHEIM GMBH
|
|||
|
By:
|
/s/ Suresh H. Vazirani | |
Suresh H. Vazirani, | |||
Chief Executive Officer and Managing Director | |||
Date: July 5, 2011
|
TRANSASIA BIO-MEDICALS LTD.
|
|||
|
By:
|
/s/ Suresh H. Vazirani | |
Suresh H. Vazirani, | |||
Chairman and Managing Director | |||
Date: July 5, 2011
|
ERBA LACHEMA S.R.O.
|
|||
|
By:
|
/s/ Suresh H. Vazirani | |
Suresh H. Vazirani, | |||
Statutory Body | |||
Date: July 5, 2011
|
SURESH H. VAZIRANI
|
|||
|
/s/ Suresh H. Vazirani
|
||
Suresh H. Vazirani | |||
Date: July 5, 2011
|
KISHORE DUDANI
|
|||
|
/s/ Kishore Dudani
|
||
Kishore Dudani | |||
Date: July 5, 2011
|
1 Year Ivax Diagnostics Chart |
1 Month Ivax Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions